ePedigree Software Market

Global ePedigree Software Market Size (2023 to 2028)

The global ePedigree software market is estimated to grow at a CAGR of 17.44% from 2023 to 2028.

ePedigree is a document used in pharmaceutical organizations to reduce counterfeit drugs. It gives complete information on changes in ownership of a pharmaceutical product from the start with the manufacturer until it reaches the person or organization in the final. The ePedigree document contains the history of the product movement, the date of those transactions, and all details of all parties involved in the drug transfer. Several states have already adopted this software for better tracking of drugs. The main aim of this software is to protect consumers from counterfeit drugs.

MARKET DRIVERS:

Growing adoption of ePedigree software, increasing need for product tracking, and technological developments in improving the pharma supply chain are propelling the ePedigree software market.

Pharmaceutical drug tracking is complex. ePedigree software was chosen by organizations to prevent drug trafficking and counterfeiting.  The Pedigree software information facts include serial numbers, item-to-package ratios, and predetermined bundles.  Tracking starts from the transactions' date and all parties' names and addresses. Each pharmaceutical company handling the product must carry forward all the previous e-pedigree information when it moves from one place to another. When it reaches its destination, the retailer will have a complete document showing where that shipment has been and who handled it.

The growth of the ePedigree software market is further anticipated to be driven by the demand for data security.

Launching the RFID Data Management Server will help pharmaceutical companies adhere to various state pedigree regulations. Pharmaceutical businesses can produce, send, receive, authenticate, and digitally sign electronic pedigree records by state laws due to e-Pedigree management. In this way, ePedigree software provides security to the data.

Governments and pharmaceutical companies consider that by introducing product serialization, counterfeiting can be reduced.  All these companies are taking measures to meet the new Drug Quality Security Act in 2017 to reduce drug counterfeiting and product diversion when they face the challenge of adopting serialization and tracking systems for both self-interests. Serialization requires constant monitoring of the path of pharmaceuticals throughout the whole supply chain. Each product is identified by a unique serial number, shelf life, and batch-wide variation of that product.

MARKET RESTRAINTS:

High costs associated with the software and maintenance, increasing security issues, and lack of awareness are some factors restraining the ePedigree software market. Low investment in anti-counterfeiting technology is the major challenge for market growth.

This report on the global ePedigree software market has been segmented and sub-segmented into the following categories.

Global ePedigree Software Market – By Type:

• Software
• Services

Global ePedigree Software Market – By Deployment Mode:

• On-premises
• Cloud

Global ePedigree Software Market – By Application:

• Hospital Pharmacies
• Retail Pharmacies
• Pharmaceutical Factory
• Online Pharmacies

Based on the application, the pharmaceutical factory segment accounted for the most significant share of the global ePedigree software market in 2021. The domination of this segment is anticipated to continue throughout the forecast period owing to increasing awareness regarding certain supply chain tracks and the rapid development of technology. The pharmaceutical track and trace system allows tracking a medicine along the supply chain. There some benefits of using ePedigree software in the pharmaceutical industry are protecting human health, increasing efficiency in production sales channels, reducing theft and fraud rates, and preventing counterfeit drugs from entering the supply chain.

Global ePedigree Software Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Due to the presence of serialization standards and advanced healthcare infrastructure, North America led the market for the ePedigree software market in 2021. Due to the increase of fake prescription pharmaceuticals mixed with real ones in the U.S., pedigree laws are now being adopted. Health Canada is taking care of the US ePedigree to introduce rules in the next few years. It also manages vaccine supply and product standards. Due to the increase in Counterfeit drugs in the supply chain in this region, Americans are more focused on tracking drug movements from start to end. For this, they adopted pedigree drug law in this region.

Europe had the second-largest share of the global market in 2022. European regulation aims to regulate medicine serialization and verification. The European Union (EU) has fought against counterfeit medications with the approval of the Falsified Medicine Directive in 2011. The sale of counterfeit products has increased during the COVID-19 epidemic, according to a new assessment of the danger posed by intellectual property crime that the European Union Intellectual Property Office jointly published. Demand for fake goods has increased because of the health crisis, resulting in the development of the market in this region.

The Asia Pacific is anticipated to have the fastest CAGR during the forecast period. In India, smaller pharma companies can produce drugs at low costs due to the simple availability of a low-cost and high-quality workforce. However, using ePedigree software to prevent the use of fake drugs may be necessary because of the potential production of counterfeit drugs.

KEY MARKET PLAYERS:

The list of major market participants profiled in this report is Altair Engineering Inc., Antares Vision SpA, Axway Software SA, Blue Yonder Group Inc., International Business Machines Corp., Merit Solutions Inc., Oracle Corp., SAP SE, Siemens AG, and TraceLink Inc.

RECENT HAPPENINGS IN THIS MARKET:

• With the recent advancement of the track-and-trace unit of the Korber Business Area Pharma, OPTEL GROUP is expanding its expansion in 2022.